Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00730_DB00831_nanopub.RA96W3IdNB9YGwByg4mjyR9oIfxEHgsMRaGih577jA4RU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00730_DB00831 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00730_DB00831 label "DDI between Thiabendazole and Trifluoperazine - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Trifluoperazine by decreasing Trifluoperazine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Trifluoperazine if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00730_DB00831]" assertion.
- drugbank_resource:DB00730_DB00831 identifier "drugbank_resource:DB00730_DB00831" assertion.
- drugbank_resource:DB00730_DB00831 title "DDI between Thiabendazole and Trifluoperazine - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Trifluoperazine by decreasing Trifluoperazine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Trifluoperazine if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00730_DB00831 assertion.
- drugbank:DB00831 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00730_DB00831 assertion.